Preclinical studies propose that retatrutide may perhaps influence obesity-linked most cancers development. In a research led by Marathe et al., retatrutide-induced weight loss lowered tumor engraftment, delayed tumor onset, and appreciably attenuated tumor growth in pancreatic and lung cancer designs, with increased tumor suppression when compared